J. Michael Gaziano - Concepedia

Author

J. Michael Gaziano

Also Known As

Andrew J. Lotery, Benjamin F. Voight, Chan, A.T., Charles Fuchs, Christopher J O’Donnell, Daniel J. Buysse, Eimear E. Kenny, Elizabeth Hauser, Foretova, Lenka, Gaziano, J Michael

961

Publications

67.7K

Citations

136

H-Index

284

Concepts

All Affiliations

Harvard University Brigham and Women's Hospital VA Boston Healthcare System Boston University Geriatric Research Education and Clinical Center

About

J. Michael Gaziano is an author at Harvard University specializing in medicine, public health, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	18	27	2.4K
2	Management	2	3	269
3	Business	1	1	11
4	Education	1	1	264
5	Engineering	1	1	147

J. Michael Gaziano

403

Publications

50.9K

Citations

115

H-Index

Page 1

	Year	Citations
Lack of Effect of Long-Term Supplementation with Beta Carotene on the Incidence of Malignant Neoplasms and Cardiovascular Disease Charles H. Hennekens, Julie E. Buring, JoAnn E. Manson, New England Journal of Medicine	1996	2.4K
Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers Scott M. Lippman, Eric A. Klein, Phyllis J. Goodman, JAMA	2008	2.1K
A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women Paul M. Ridker, Nancy R. Cook, I‐Min Lee, New England Journal of Medicine	2005	1.9K
Vitamin E and the Risk of Prostate Cancer Eric A. Klein, Ian M. Thompson, Catherine M. Tangen, JAMA	2011	1.7K
Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer I‐Min Lee, Nancy R. Cook, J. Michael Gaziano, JAMA	2005	1.1K
Soft Drink Consumption and Risk of Developing Cardiometabolic Risk Factors and the Metabolic Syndrome in Middle-Aged Adults in the Community Ravi Dhingra, Lisa Sullivan, Paul F. Jacques, Circulation	2007	926
C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction Paul M. Ridker, Nina P. Paynter, Nader Rifai, Circulation	2008	849
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial J. Michael Gaziano, Carlos Brotons, Rosa Coppolecchia, The Lancet ThrombosisHypertensionCardiovascular DiseaseMedicineModerate Risk	2018	849
Low-Dose Aspirin in the Primary Prevention of Cancer Nancy R. Cook, I‐Min Lee, J. Michael Gaziano, JAMA	2005	781
Sex Hormone–Binding Globulin and Risk of Type 2 Diabetes in Women and Men Eric L. Ding, Yiqing Song, JoAnn E. Manson, New England Journal of Medicine	2009	713

Page 1